Physical Activity and Patient-Reported Outcomes in Monoclonal Plasma Cell DisordersMEDICINE & SCIENCE IN SPORTS & EXERCISEIF3.92023-07-031PRE
Integrative medicine in multiple myeloma and plasma cell disordersCOMPLEMENTARY THERAPIES IN MEDICINEIF3.52023-05-012OAAI
What are the top myeloma patient concerns at and since diagnosis of Mexicans, Hispanics and Latinos?CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42023-01-010PRE
HealthTree Cure Hub: A Patient-Derived, Patient-Driven Clinical Cancer Information Platform Used to Overcome Hurdles and Accelerate Research in Multiple MyelomaJCO CLINICAL CANCER INFORMATICSIF2.82022-05-014OAAI
Nutrition perceptions, needs and practices among patients with plasma cell disordersBLOOD CANCER JOURNALIF11.62022-04-206OAAI
Clinical Characteristics of 18 Patients with Psoriasis and Multiple Myeloma Identified Through Digital Health CrowdsourcingDERMATOLOGY AND THERAPYIF4.22020-07-077OAAI
The consequence of obesity and obstructive sleep apnea in liver cancerCANCER RESEARCHIF16.62016-07-150PRE
ARE CONDITIONALLY APPROVED THERAPIES SUCCESSFUL IN GAINING MARKET ACCESS?VALUE IN HEALTHIF62013-11-010OAAI
ARE ICER THRESHOLD VALUES MALLEABLE? THE CASE OF LIFE-EXTENDING CANCER TREATMENTS AT THE END OF LIFEVALUE IN HEALTHIF62013-11-011OAAI
DO NICE EVIDENCE REVIEW GROUPS (ERG) FOCUS ON DIFFERENT ASPECTS OF MANUFACTURER SUBMISSIONS IN ONCOLOGY?VALUE IN HEALTHIF62013-11-011OAAI
EVALUATION OF CURRENT HEALTH TECHNOLOGY ASSESSMENTS FOR RHEUMATOID ARTHRITIS - AN INSIGHT INTO THE KEY UNCERTAINTIES GENERATED BY THE AVAILABLE EVIDENCEVALUE IN HEALTHIF62012-11-010OAAI
PAYER VALUE IN ALTERNATIVE TREATMENT FORMULATIONS: ACCESS TO NEW MEDICINES IN SCHIZOPHRENIAVALUE IN HEALTHIF62012-11-010OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向